ATE469902T1 - Amorphe substanz eines tricyclischen triazolobenzazepinderivats - Google Patents

Amorphe substanz eines tricyclischen triazolobenzazepinderivats

Info

Publication number
ATE469902T1
ATE469902T1 AT02790871T AT02790871T ATE469902T1 AT E469902 T1 ATE469902 T1 AT E469902T1 AT 02790871 T AT02790871 T AT 02790871T AT 02790871 T AT02790871 T AT 02790871T AT E469902 T1 ATE469902 T1 AT E469902T1
Authority
AT
Austria
Prior art keywords
amorphous substance
derivative
tricyclic triazolobenzazepine
tricyclic
triazolobenzazepine derivative
Prior art date
Application number
AT02790871T
Other languages
English (en)
Inventor
Toyoaki Ishikura
Takayuki Ishizawa
Kenji Suemune
Mayumi Ishiwata
Chikako Udagawa
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE469902T1 publication Critical patent/ATE469902T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02790871T 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats ATE469902T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001393016 2001-12-26
PCT/JP2002/013558 WO2003055886A1 (en) 2001-12-26 2002-12-25 Amorphous substance of tricyclic triazolobenzazepine derivative

Publications (1)

Publication Number Publication Date
ATE469902T1 true ATE469902T1 (de) 2010-06-15

Family

ID=19188739

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02790871T ATE469902T1 (de) 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats
AT02790870T ATE410427T1 (de) 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02790870T ATE410427T1 (de) 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat

Country Status (11)

Country Link
US (2) US7002009B2 (de)
EP (2) EP1466914B1 (de)
JP (2) JPWO2003055885A1 (de)
KR (1) KR100848724B1 (de)
CN (1) CN1275968C (de)
AT (2) ATE469902T1 (de)
AU (2) AU2002367110A1 (de)
CA (1) CA2471651C (de)
DE (2) DE60229298D1 (de)
ES (2) ES2346858T3 (de)
WO (2) WO2003055886A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113343A1 (ja) * 2003-06-19 2004-12-29 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
WO2004113424A1 (ja) * 2003-06-20 2004-12-29 Meiji Seika Kaisha, Ltd. 難水溶性物質と水溶性高分子との共沈物の製造方法
WO2007100079A1 (ja) * 2006-03-02 2007-09-07 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤
TW200843903A (en) * 2007-05-03 2008-11-16 Univ Nat Central Abrasives with function of sliding grinding and its manufacturing method
BRPI0821302A8 (pt) * 2007-12-18 2015-12-08 Meiji Seika Kaisha Composição farmacêutica, método para prevenir ou tratar doenças do intestino inflamatórias, e, uso de um composto
JP5381978B2 (ja) * 2008-04-02 2014-01-08 アステラス製薬株式会社 アミド誘導体含有医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW486480B (en) * 1996-03-08 2002-05-11 Zeneca Ltd Azolobenzazepine derivatives and compositions and method of use thereof
US6574603B1 (en) * 1997-09-26 2003-06-03 Gilbarco Inc. In-vehicle ordering
RU2198885C2 (ru) * 1997-09-29 2003-02-20 Мейдзи Сейка Кайся Лтд. Производные трициклического триазолобензазепина, способы их получения, фармацевтическая композиция и способ лечения аллергических заболеваний, промежуточные соединения и способы их получения

Also Published As

Publication number Publication date
EP1469000B1 (de) 2008-10-08
KR20040072682A (ko) 2004-08-18
EP1469000A4 (de) 2005-12-07
DE60229298D1 (de) 2008-11-20
US20050020579A1 (en) 2005-01-27
CA2471651A1 (en) 2003-07-10
US20050130955A1 (en) 2005-06-16
ATE410427T1 (de) 2008-10-15
EP1466914A4 (de) 2005-12-07
US7229985B2 (en) 2007-06-12
ES2312650T3 (es) 2009-03-01
JP4376628B2 (ja) 2009-12-02
WO2003055885A1 (en) 2003-07-10
AU2002367109A1 (en) 2003-07-15
KR100848724B1 (ko) 2008-07-25
ES2346858T3 (es) 2010-10-21
AU2002367110A1 (en) 2003-07-15
EP1466914A1 (de) 2004-10-13
EP1469000A1 (de) 2004-10-20
JPWO2003055885A1 (ja) 2005-05-12
CN1275968C (zh) 2006-09-20
CN1617872A (zh) 2005-05-18
WO2003055886A1 (en) 2003-07-10
JPWO2003055886A1 (ja) 2005-09-02
DE60236623D1 (de) 2010-07-15
US7002009B2 (en) 2006-02-21
CA2471651C (en) 2010-01-26
EP1466914B1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
EE200100594A (et) Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel
ATE431733T1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
IL160051A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
SE9900100D0 (sv) New compounds
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
ATE350036T1 (de) Tetrahydroquinolin-derivate
PT1191025E (pt) Cristais de lansoprazol
DK1216225T3 (da) Nye aminodicarboxylsyrederivater med farmaceutiske egenskaber
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE340177T1 (de) 12,13-modifizierte epothilon-derivate
ATE302782T1 (de) Substituierte 1-oxa-2,8-diaza-spiro(4,5)dec-2-en- derivate als arzneimittel gegen schmerz
ATE465733T1 (de) Substituierte indeno-ä1,2-cü-isochinolin-derivate und verwendungszwecke dafür
MA27349A1 (fr) Composition cristalline renfermant de l'escitalopram.
AU2002349777A1 (en) Novel benzophenone derivatives or salts thereof
MA26845A1 (fr) Forme cristalline de 4-carboxyamino-2-ethyl-1,2,3,4-
FR2806720B1 (fr) Derives de 2,2,6,6-diethyl-dimethyl-1-alcoxypiperidines et 1-oxydes correspondants
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
ATE469902T1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
NO20013878D0 (no) (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties